You can help expand this article with text translated from the corresponding article in German. (August 2018) Click [show] for important translation instructions.
|
Konrad Beyreuther (born 14 May 1941) is a German molecular biologist and chemist known for his work on neurodegenerative diseases.
Konrad Beyreuther | |
|---|---|
| Born | 14 May 1941 Leutersdorf, Germany |
| Nationality | German |
| Education | Max Planck Institute for Biochemistry (Dr.rer.nat. 1968) |
| Known for | neurodegenerative diseases |
| Awards | Feldberg Award (1989) Metlife Foundation Award (1990) Potamkin Prize (1990) King Faisal International Prize in Medicine (1997) |
| Scientific career | |
| Fields | molecular biology |
| Institutions | Heidelberg University Cologne University |
| Doctoral advisor | Adolf Butenandt |
Life
editKonrad Bayreuther was the son of an evangelical pastor. He studied chemistry at the Ludwigs-Maximilians-Universität (LMU) in Munich. He wrote his PhD Thesis at the Max-Planck Institut für Biochemie in Munich. Until 1978 he was a scientific employee at the Institut for genetics at the university of Cologne.
Until 1987 he was a professor at the university of Cologne. From 1987 onwards he has held various positions at the University of Heidelberg.
Works
editBeyreuther's work with Colin L. Masters implicated amyloid precursor protein (APP) as a possible precursor of Alzheimer's disease.[1] Together with British researchers, he discovered the pathogenic prion that causes BSE, also known as mad cow disease, in 1998.[2]
Awards
editBayreuther received the Robert Pfleger Research Award in 1988 and the Feldberg Award in 1989. In 1990, he won the Metlife Foundation Award for Medical Research in Alzheimer's Disease[3] with Robert D. Terry and was awarded the Potamkin Prize jointly with Masters.[4] Beyreuther and Masters both received Max Planck Research Awards in 1991,[5] and shared the Zülch Prize in 1995.[6] In 1997 they were awarded the King Faisal International Prize in Medicine together with James F. Gusella for contributions to the understanding of neurodegenerative diseases.[7] Bayreuther has been elected to the German Academy of Sciences Leopoldina, the Heidelberg Academy for Sciences and Humanities, and the Göttingen Academy of Sciences. He is a recipient of the Order of Merit of Baden-Württemberg and the Cross of the Order of Merit of the Federal Republic of Germany.
References
edit- ^ Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985). "Amyloid plaque core protein in Alzheimer disease and Down syndrome". Proc Natl Acad Sci U S A. 82 (12): 4245–9. Bibcode:1985PNAS...82.4245M. doi:10.1073/pnas.82.12.4245. PMC 397973. PMID 3159021.
- ^ Hope, James; Reekie, Laura J. D.; Hunter, Nora; Multhaup, Gerd; Beyreuther, Konrad; White, Heather; Scott, Anthony C.; Stack, Michael J.; Dawson, Michael; Wells, Gerald A. H. (1988). "Fibrils from brains of cows with new cattle disease contain scrapie-associated protein". Nature. 336 (6197). Springer Nature: 390–392. Bibcode:1988Natur.336..390H. doi:10.1038/336390a0. ISSN 0028-0836. PMID 2904126. S2CID 4351199.
- ^ "Winners". MetLife Foundation Awards in Medical Research. Archived from the original on 23 January 2012. Retrieved 18 October 2018.
- ^ "Awards History". American Academy of Neurology. Retrieved 30 September 2018.
- ^ "Max-Planck-Forschungspreis" [Max Planck Research Award]. Max-Planck-Gesellschaft (in German). Archived from the original on 25 September 2009. Retrieved 30 September 2018.
- ^ "Zülch Prize". Max-Planck-Gesellschaft. 26 September 2018. Retrieved 30 September 2018.
- ^ "Professor Konrad Beyreuther". King Faisal Prize. 10 October 2012. Retrieved 13 August 2018.
  | This article about a German scientist is a stub. You can help Wikipedia by expanding it. |